Mr. Dvorak is a distinguished business leader with over 20 years of executive operating experience with global healthcare technology companies. He served in various executive positions with Zimmer Biomet Holdings, Inc. from 2001 to 2017, including as President and Chief Executive Officer from 2007 to 2017. During his tenure, Zimmer Biomet was built into a Fortune 500 Company with revenues growing from $1.2 billion to $7.7 billion and market capitalization appreciating from $6.2 billion to $25.8 billion. Mr. Dvorak was also previously an executive officer with STERIS plc from 1996 to 2001. In addition, he served on the Boards of Directors of St. Jude Medical, Inc. from 2015 to 2016 and the Advanced Medical Technology Association (AdvaMed) from 2007 to 2017, including as Chairman from 2012 to 2014. He currently also serves on the Boards of Directors of Mach Medical, LLC, Mesentech Inc., Insurgical, Inc., THINK Surgical, Inc. and Beyond Cancer, Ltd.
Mr. Dvorak holds a Bachelor of Science in Business Administration (Finance) from Miami University (OH) and a J.D., magna cum laude, from Case Western Reserve University School of Law, where he was elected to the Order of the Coif.